Cargando…

Ethnicity and Second-Line Antihypertensive Medication Response in the ASCOT Trial

Detalles Bibliográficos
Autores principales:	Davis, Jason T., Fung, Maple M.
Formato:	Texto
Lenguaje:	English
Publicado:	Current Science Inc. 2010
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016019/ https://www.ncbi.nlm.nih.gov/pubmed/21080239 http://dx.doi.org/10.1007/s11906-010-0169-4

Ejemplares similares

Long-Term Incidence of Stroke and Dementia in ASCOT
por: Whiteley, William N., et al.
Publicado: (2021)

The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer
por: Claessens, Anouk K. M., et al.
Publicado: (2019)

The electronics of the ASCOT project
por: Wingerter, W
Publicado: (1991)

Exploring the structural characteristics of the Adult Social Care Outcomes Toolkit (ASCOT) and ASCOT-Carer
por: Rand, Stacey, et al.
Publicado: (2023)

ASCOT pips SARS at the post
Publicado: (2003)

Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial
por: Stockton, Shannon, et al.
Publicado: (2023)

Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease
por: Whone, Alan, et al.
Publicado: (2019)

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2018)

Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma
por: Yoon, Harry, et al.
Publicado: (2018)

Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials
por: Kanapuru, Bindu, et al.
Publicado: (2022)

The ASCOT detector at the LHC: expression of interest
por: Norton, Peter R
Publicado: (1992)

Feasibility, validity and reliability of the ASCOT-Proxy and ASCOT-Carer among unpaid carers of people living with dementia in England
por: Silarova, Barbora, et al.
Publicado: (2023)

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
por: Di Pierro, Francesco, et al.
Publicado: (2021)

Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
por: Abramson, Jeremy S., et al.
Publicado: (2023)

Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication
por: Weiss, Glen J., et al.
Publicado: (2019)

Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial
por: Pijpers, Judith A, et al.
Publicado: (2019)

The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial
por: Dalla Bella, Eleonora, et al.
Publicado: (2021)

Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?
por: Schaefgen, Benedikt, et al.
Publicado: (2021)

Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
por: Elsawy, Mahmoud, et al.
Publicado: (2022)

Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine
por: Collins, Alexis, et al.
Publicado: (2021)

Heatherwood Hospital, Ascot: Healing by Natural Conditions
Publicado: (1923)

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
por: Rivera, Fernando, et al.
Publicado: (2019)

Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study
por: Hu, Zhihuang, et al.
Publicado: (2022)

Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma
por: Peres, Lauren C., et al.
Publicado: (2022)

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
por: Esserman, Laura J., et al.
Publicado: (2011)

Three-Dimensional Heads-up Cataract Surgery Using Femtosecond Laser: Efficiency, Efficacy, Safety, and Medical Education—A Randomized Clinical Trial
por: Wang, Kai, et al.
Publicado: (2021)

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis
por: Mease, Philip J., et al.
Publicado: (2020)

Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled Trial
por: Blair, Gordon W., et al.
Publicado: (2021)

Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination
por: Swain, Sandra M., et al.
Publicado: (2019)

The effects of a dyadic strength-based empowerment program on the health outcomes of people with mild cognitive impairment and their family caregivers: a randomized controlled trial
por: Yu, Doris Sau-Fung, et al.
Publicado: (2019)

Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology
por: Garnett, Sally Anne, et al.
Publicado: (2013)

Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer
por: Goncalves, Rodrigo, et al.
Publicado: (2017)

A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma
por: Hecht, J. Randolph, et al.
Publicado: (2017)

Adhesion prevention after endometriosis surgery — results of a randomized, controlled clinical trial with second-look laparoscopy
por: Krämer, Bernhard, et al.
Publicado: (2021)

Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial
por: Bladin, Christopher F., et al.
Publicado: (2023)

Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial
por: Welt, A., et al.
Publicado: (2016)

Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial
por: Law, Zhe Kang, et al.
Publicado: (2021)

A nurse-based intervention for improving medication adherence in cardiovascular patients: an evaluation of a randomized controlled trial
por: Sieben, Angelien, et al.
Publicado: (2019)

A pilot randomized controlled clinical trial of second uterine curettage versus usual care to determine the effect of re-curettage on patients’ need for chemotherapy among women with low risk, nonmetastatic gestational trophoblastic neoplasm in Urmia, Iran
por: Ayatollahi, Haleh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hhf1at9nijpvuu0sclk7fufi76